Sigma Healthcare Limited

Equities

SIG

AU000000SIG5

Pharmaceuticals

Market Closed - Australian S.E. 01:10:10 2024-03-28 am EDT 5-day change 1st Jan Change
1.295 AUD +0.39% Intraday chart for Sigma Healthcare Limited +6.58% +28.86%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Miners, healthcare firms push Australia stocks higher RE
Morgans Financial Downgrades Sigma Healthcare to Hold From Add; Price Target is AU$1.14 MT
Sigma Healthcare Posts Higher Profit, Lower Sales Revenue in FY24 MT
Transcript : Sigma Healthcare Limited, 2024 Earnings Call, Mar 21, 2024
Sigma Healthcare Limited Reports Earnings Results for the Full Year Ended January 31, 2024 CI
Barrenjoey Starts Sigma Healthcare at Overweight With AU$1.30 Price Target MT
Sigma Healthcare Raises AU$223 Million Via Retail Entitlement Offer MT
Sigma Healthcare Raises AU$178 Million Via Institutional Entitlement Offer MT
Australian shares end higher; all eyes on Fed policy decision RE
Financials push Australian shares higher; Fed in focus RE
Health Care Climbs on Deal Intrigue -- Health Care Roundup DJ
News Highlights : Top Company News of the Day DJ
Australia shares climb on rate-cut hopes; employment data in focus RE
Transcript : Cw Group Holdings Limited, Sigma Healthcare Limited - M&A Call
CW Group Holdings Limited agreed to acquire Sigma Healthcare Limited in reverse merger transaction. CI
Vitura Health Limited completed the acquisition of an unknown minority stake in Doctors on Demand from Tacos Superannuation Fund, Martin Superannuation Fund, Sigma Company Limited, and Regal Emerging Companies Opportunities Fund and Regal Emerging Companies Fund III managed by Regal Partners Limited. CI
Vitura Health Limited entered into share sale agreement to acquire an unknown minority stake in Doctors on Demand from Tacos Superannuation Fund, Martin Superannuation Fund, Sigma Company Limited, and Regal Emerging Companies Opportunities Fund and Regal Emerging Companies Fund III managed by Regal Partners Limited. CI
Sigma Healthcare Limited Announces Christopher Graham Roberts as Director CI
Sigma Healthcare Limited Announces Executive Changes CI
Transcript : Sigma Healthcare Limited, H1 2024 Earnings Call, Sep 20, 2023
Sigma Healthcare Limited Declares Fully Franked Dividend for the Six Month Ended July 31, 2023, Payable on October 11, 2023 CI
Sigma Healthcare Limited Reports Earnings Results for the Half Year Ended July 31, 2023 CI
Sigma Healthcare Limited Appoints Mark Conway as CFO, Effective from 1 November 2023 CI
Sigma Healthcare CFO Resigns MT
Sigma Healthcare Limited Announces Executive Changes CI
Chart Sigma Healthcare Limited
More charts
Sigma Healthcare Limited is an Australia-based company. The principal activities of the Company are the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies. Its brands include Amcal, Guardian, and Discount Drug Stores. The Company provides a range of solutions, including dispensary services, data and technology, health services, team training, private and exclusive label, sigma rewards, sigma financial services, and supply network and logistics. Its dispensary services provide pharma program, sigma ethical partnership program, and dose administration aid program. Its data and technology provide e-prescription support, health opportunities and sigma performance dashboard tool. Its health services include pharmacy practice support, LEAPP dispensary program, PSS sleep apnoea program and sigma dose administration aid program. Its team training involves sigma online training platform, retail pharmacy programs, and quality care resource hub.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
1.295 AUD
Average target price
1.118 AUD
Spread / Average Target
-13.71%
Consensus
  1. Stock
  2. Equities
  3. Stock Sigma Healthcare Limited - Australian S.E.
  4. News Sigma Healthcare Limited
  5. Sigma Healthcare Scraps Takeover Offer for Australian Pharmaceutical Industries Amid 'Competitive Bid Process'